Site icon pharmaceutical daily

Molecular Diagnostics Markets for Infectious Diseases, 2021-2024: Multiplex Testing Threatens Existing Assays / Test Speed Taking Centre Stage –

DUBLIN–(BUSINESS WIRE)–The “Molecular Diagnostics for Infectious Disease Market Report 2021” report has been added to’s offering.

A market that just keeps on growing. In spite of the steady decline of disease prevalence, the diagnostic sector keeps growing. Find out why in the informative report. And find out about the exciting developments in multiplex assays which threaten to change diagnosis and treatment while limiting the threat of anti microbial drug resistance.

Key Insights

Learn all about it in this new report. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

Exciting technical developments especially in the seesaw between sequencing and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication.

The report has hundreds of pages of information including a complete list of Current 2016 United States Medicare Fee Payment Schedules to help sharpen your pricing. Again, assistance in using the information is normally provided without additional charges.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Key Topics Covered:

1. Introduction and Market Definition

1.1 What is Molecular Diagnostics

1.2 The Diagnostics Revolution

1.3 Market Definition

1.3.1 Volumes

1.3.2 Prices

1.3.3 Revenue Market Size

1.4 Methodology

1.5 U.S. Medical Market and Clinical Laboratory Testing – Perspective

1.5.1 U.S. Medicare Expenditures for Clinical Testing

2. The Infectious Diseases – Market Analysis by Disease

2.1 HIV – Human Immunodeficiency Virus (AIDS)

2.1.1 Virology Classification Structure and genome Tropism Replication cycle Genetic variability

2.1.2 Diagnosis

2.1.3 Testing

2.1.4 Market Opportunity Analysis

2.2 HBV – Hepatitis B

2.2.1 Virology

2.2.2 Mechanisms

2.2.3 Diagnosis

2.2.4 Market Opportunity Analysis

2.3 HCV – Hepatitis C

2.3.1 Taxonomy

2.3.2 Structure

2.3.3 Molecular biology

2.3.4 Replication

2.3.5 Genotypes Clinical importance

2.3.6 Market Opportunity Analysis

2.4 HPV – Human papillomavirus

2.5 Influenza

2.6 CTGC – Chlamydia/Gonorhea

2.7 Tuberculosis

2.8 MRSA – Methicillin-resistant Staphylococcus aureus

2.8.1 Diagnosis

2.8.2 FDA Approved Molecular Tests

2.8.3 Market Opportunity Analysis

2.9 VRE – Vancomycin-resistant Enterococcus

2.9.1 FDA Approved MDx Tests for VRE

2.9.2 Market Opportunity Analysis

2.10 Blood Screening

2.10.1 Collection and Testing

2.10.2 FDA Approved Multiplex Assays

2.10.3 Market Opportunity Analysis

3. Industry Overview

3.1 Industry Participants

3.1.1 IVD Supplier

3.1.2 Independent lab specialized/esoteric

3.1.3 Independent lab national/regional

3.1.4 Independent lab analytical

3.1.5 Public National/regional lab

3.1.6 Hospital lab

3.1.7 Physician lab

3.1.8 Audit body

3.2 The Clinical Laboratory Market Segments

3.2.1 Traditional Market Segmentation

3.2.2 Laboratory Focus and Segmentation

3.3 Industry Structure

3.3.1 Hospital Testing Share

3.3.2 Economies of Scale

3.3.3 Physician Office Lab’s

3.3.4 Physician’s and POCT

3.4 Profiles of Key MDx Companies

4. Market Trends

4.1 Factors Driving Growth

4.1.1 New Genotypes Creating New Markets

4.1.2 Aging Population a Boon for All Diagnostics

4.1.3 Developing World Driving ID Dx Growth

4.1.4 Point of Care – Why Centralization is Losing Steam

4.1.5 Self Testing

4.1.6 The Need for Speed

4.2 Factors Limiting Growth

4.2.1 Lower Costs

4.2.2 Infectious Disease is Declining

4.2.3 Wellness Hurts

4.2.4 Economic Growth improves Living Standards

4.3 Instrumentation and Automation

4.3.1 Instruments Key to Market Share

4.3.2 The Shrinking Machine.

4.3.2 Multiplex, Point of Care and The Speed Factor

4.4 Diagnostic Technology Development

4.4.1 The Sepsis Testing Market – A New Direction?

4.4.2 POCT/Self Testing as a Disruptive Force

4.4.3 The Genetics Play – One Test for All Known Infections

4.4.4 Antibiotic Resistance Genes – Simplifying Diagnostics

5. Molecular Dx – Infectious Disease Recent Developments

6. The Global Market for Molecular Diagnostics Infectious Disease

6.1 Global Market Overview by Country

6.2 Global Market by Syndrome-Overview

7. Global Molecular Diagnostics Infectious Disease Markets-By Syndrome

7.1 Respiratory

7.2 Gastrointestinal

7.3 Blood

7.4 Meningitis/Encephalitis

7.5 Sexually Transmitted Disease

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version